Literature DB >> 17167139

Medical progress: Acromegaly.

Shlomo Melmed1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167139     DOI: 10.1056/NEJMra062453

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  335 in total

1.  Oral estroprogestin: an alternative low cost therapy for women with postoperative persistent acromegaly?

Authors:  Sophie Vallette; Omar Serri
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

2.  Reports of increased mortality and GH: will this affect current clinical practice?

Authors:  Saul Malozowski
Journal:  J Clin Endocrinol Metab       Date:  2012-02       Impact factor: 5.958

3.  Pituitary gland: New consensus in acromegaly: criteria for cure and control.

Authors:  Nienke Biermasz
Journal:  Nat Rev Endocrinol       Date:  2010-09       Impact factor: 43.330

4.  Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study.

Authors:  Vivien Bonert; John Carmichael; Zengru Wu; James Mirocha; Daniel A Perez; Nigel J Clarke; Richard E Reitz; Michael J McPhaul; Adam Mamelak
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

5.  Voice characteristics of acromegaly.

Authors:  Kadriye Aydin; Didem Turkyilmaz; Burak Ozturk; Selcuk Dagdelen; Burce Ozgen; Faruk Unal; Tomris Erbas
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-07       Impact factor: 2.503

6.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

7.  IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomas.

Authors:  Amit Akirov; Yona Greenman; Benjamin Glaser; Irena S'chigol; Yossi Mansiterski; Yoav Eizenberg; Ilana Shraga-Slutzky; Ilan Shimon
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

8.  Elevated intraocular pressure in patients with acromegaly.

Authors:  Luciano Quaranta; Ivano Riva; Gherardo Mazziotti; Teresa Porcelli; Irene Floriani; Andreas Katsanos; Andrea Giustina; Anastasios G P Konstas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-10       Impact factor: 3.117

9.  Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy.

Authors:  E Ghigo; B M K Biller; A Colao; I A Kourides; N Rajicic; R K Hutson; L De Marinis; A Klibanski
Journal:  J Endocrinol Invest       Date:  2009-12-04       Impact factor: 4.256

Review 10.  Skin manifestations of growth hormone-induced diseases.

Authors:  Christina Kanaka-Gantenbein; Christina Kogia; Mohamed Badawy Abdel-Naser; George P Chrousos
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.